Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry B Strom

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Current Opinion in Immunology|August 17, 2002
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicineTerry B Strom, Loren J Field, Manfred Ruediger
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanismsGulcin Demirci, Terry B Strom, Xian Chang Li
Cold Spring Harbor Perspectives in Medicine|December 28, 2013
Tolerance--is it worth it?Erik B Finger, Terry B Strom, Arthur J Matas
Immunity|February 21, 2004
Routes to transplant tolerance versus rejection; the role of cytokinesPatrick T Walsh, Terry B Strom, Laurence A Turka
Cell Transplantation|March 29, 2011
Rapamycin generates graft-homing murine suppressor CD8(+) T cells that confer donor-specific graft protectionBasset El Essawy, Prabhakar Putheti, Wenda Gao, et al.
Transplantation|September 26, 2003
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survivalWenda Gao, Gülçin Demirci, Terry B Strom, et al.
Immunological Reviews|November 18, 2003
The balance of deletion and regulation in allograft toleranceXin Xiao Zheng, Alberto Sanchez-Fueyo, Christoph Domenig, et al.
Nanobiomedicine|June 27, 2018
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIFSu M Metcalfe, Terry B Strom, Anna Williams, et al.
Transplantation|March 24, 2005
Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejectionMinh Diem Vu, Yongsheng Li, Terry B Strom, et al.
Transplantation|October 5, 2002
The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppressionAlberto Sánchez-Fueyo, Christoph Domenig, Terry B Strom, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Current Opinion in Immunology|August 17, 2002
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicineTerry B Strom, Loren J Field, Manfred Ruediger
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanismsGulcin Demirci, Terry B Strom, Xian Chang Li
Cold Spring Harbor Perspectives in Medicine|December 28, 2013
Tolerance--is it worth it?Erik B Finger, Terry B Strom, Arthur J Matas
Immunity|February 21, 2004
Routes to transplant tolerance versus rejection; the role of cytokinesPatrick T Walsh, Terry B Strom, Laurence A Turka
Cell Transplantation|March 29, 2011
Rapamycin generates graft-homing murine suppressor CD8(+) T cells that confer donor-specific graft protectionBasset El Essawy, Prabhakar Putheti, Wenda Gao, et al.
Transplantation|September 26, 2003
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survivalWenda Gao, Gülçin Demirci, Terry B Strom, et al.
Immunological Reviews|November 18, 2003
The balance of deletion and regulation in allograft toleranceXin Xiao Zheng, Alberto Sanchez-Fueyo, Christoph Domenig, et al.
Nanobiomedicine|June 27, 2018
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIFSu M Metcalfe, Terry B Strom, Anna Williams, et al.
Transplantation|March 24, 2005
Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejectionMinh Diem Vu, Yongsheng Li, Terry B Strom, et al.
Transplantation|October 5, 2002
The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppressionAlberto Sánchez-Fueyo, Christoph Domenig, Terry B Strom, et al.
Pageof 12